Literature DB >> 15720984

Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis.

Toshiyuki Itamoto1, Hideki Nakahara, Hirotaka Tashiro, Hideki Ohdan, Hiroshi Hino, Makoto Ochi, Toshimasa Asahara.   

Abstract

BACKGROUND: The appropriate treatment strategy for transplantable hepatocellular carcinoma (HCC) patients with compensated cirrhosis remains controversial.
METHODS: Surgical outcomes were reviewed in 136 cirrhotic patients with transplantable HCC who had undergone partial hepatectomy. Transplantable HCC was defined as that corresponding to Milan's criteria.
RESULTS: The adverse prognostic factors for both survival and disease-free survival were histologic surgical margin of 5 mm or less, Child-Pugh B, and the presence of hepatitis C virus infection. The overall 5-year survival and disease-free survival rates of patients with 1 or none of the adverse prognostic factors were 73% and 33%, respectively, whereas those of patients with 2 or 3 adverse prognostic factors were 36% and 17%, respectively.
CONCLUSIONS: Transplantable HCC patients with 2 or 3 adverse prognostic factors should be considered candidates for liver transplantation, whereas patients with only 1 or none of the adverse prognostic factors are good candidates for partial hepatectomy.

Entities:  

Mesh:

Year:  2005        PMID: 15720984     DOI: 10.1016/j.amjsurg.2004.11.001

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more.

Authors:  Koichi Oishi; Toshiyuki Itamoto; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

3.  Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?

Authors:  Theodoros Michelakos; Dimitrios Xourafas; Motaz Qadan; Rafael Pieretti-Vanmarcke; Lei Cai; Madhukar S Patel; Joel T Adler; Fermin Fontan; Usama Basit; Parsia A Vagefi; Nahel Elias; Kenneth K Tanabe; David Berger; Heidi Yeh; James F Markmann; David C Chang; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2018-09-14       Impact factor: 3.452

4.  Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.

Authors:  Tomoyuki Abe; Hirotaka Tashiro; Tsuyoshi Kobayashi; Minoru Hattori; Shintaro Kuroda; Hideki Ohdan
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

5.  Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria.

Authors:  Hironobu Amano; Hirotaka Tashiro; Akihiko Oshita; Tsuyoshi Kobayashi; Yoshisato Tanimoto; Shintaro Kuroda; Hirofumi Tazawa; Toshiyuki Itamoto; Toshimasa Asahara; Hideki Ohdan
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

6.  Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy.

Authors:  Saburo Fukuda; Toshiyuki Itamoto; Hironobu Amano; Toshihiko Kohashi; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

7.  Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.

Authors:  Kai-Zhong Luo; Toshiyuki Itamoto; Hironobu Amano; Akihiko Oshita; Yuichiro Ushitora; Yoshisato Tanimoto; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

8.  Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization.

Authors:  Suk Kyeong Ji; Yun Ku Cho; Yong Sik Ahn; Mi Young Kim; Yoon Ok Park; Jae Kyun Kim; Wan Tae Kim
Journal:  Korean J Radiol       Date:  2008 Nov-Dec       Impact factor: 3.500

9.  Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study.

Authors:  Yuki Imaoka; Masahiro Ohira; Koki Sato; Kouki Imaoka; Shintaro Kuroda; Hiroyuki Tahara; Tsuyoshi Kobayashi; Kentaro Ide; Yuka Tanaka; Hideki Ohdan
Journal:  Ann Gastroenterol Surg       Date:  2021-09-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.